Latest news and articles about new medications from NEX English
Patients in Greece are facing delays of up to two years in accessing new medications, with reports indicating a significant decline in the number of drugs reaching the Greek market. This situation raises alarms amid Europe's advancements in medical innovations.
Recent research indicates that new medications for chronic migraines significantly reduce the number of pain days while minimizing side effects, enhancing patients' quality of life. Migraines affect millions globally, impacting their daily lives.
Istanbul, known as the capital of hair transplantation, is facing new threats due to a revolution in medications that may impact this vital sector. Concerns are growing that these developments could lead to a decline in demand for hair transplants in the city.
The UAE has announced the approval of a new weight loss medication that is taken daily in pill form, eliminating the need for injections. This development marks a significant step in addressing obesity in the region.
Lilly has announced the launch of a new obesity treatment, generating significant interest on Wall Street despite strong competition from Novo Nordisk. The drug is expected to achieve sales in the billions.